Table 3 PGE2 concentrations in canine stifle synovial fluid following bupivacaine or saline injection in stifles requiring ≤ 2 attempts
Time | Treatment | Sample size | Median (pg/mL) | Range |
|---|---|---|---|---|
T0 | Bupivacaine* | 5 | 110.9#,§ | 58.3–382.1 |
T0 | Saline | 7 | 184.8 | 96.2–434.8 |
T30 | Bupivacaine | 6 | 239.1 | 128.9–338.3 |
T30 | Saline | 8 | 270.0 | 91.7–430.1 |
T60 | Bupivacaine | 6 | 362.4 | 142.3–669.1 |
T60 | Saline | 8 | 468.3 | 172.3–1074.2 |
T24 | Bupivacaine | 8 | 726.2# | 197.8–1675.8 |
T24 | Saline | 8 | 446.4 | 159.8–910.3 |
T48 | Bupivacaine | 6 | 391.6§ | 210.0–1722.4 |
T48 | Saline | 7 | 274.3 | 118.5–2425.9 |